C
Claudio Cerchione
Researcher at University of Naples Federico II
Publications - 143
Citations - 1188
Claudio Cerchione is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Medicine & Multiple myeloma. The author has an hindex of 10, co-authored 101 publications receiving 453 citations.
Papers
More filters
Journal ArticleDOI
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
TL;DR: This review recapitulates and discusses the most recent findings on the biological function of WEE1/PKMYT1 during the cell cycle and in the DNA damage repair, with a focus on their dual role as tumor suppressors in nonmalignant cells and pseudo-oncogenes in cancer cells.
Posted ContentDOI
A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2
Sean Nolan,Marissa Vignali,Mark Klinger,Jennifer N. Dines,Ian M. Kaplan,Emily Svejnoha,Tracy Craft,Katie Boland,Mitch Pesesky,Rachel M. Gittelman,Thomas M. Snyder,Christopher J Gooley,Simona Semprini,Claudio Cerchione,Massimiliano Mazza,Ottavia M. Delmonte,Kerry Dobbs,Gonzalo Carreño-Tarragona,Santiago Barrio,Vittorio Sambri,Giovanni Martinelli,Jason D Goldman,James R. Heath,Luigi D. Notarangelo,Jonathan M. Carlson,Joaquin Martinez-Lopez,Harlan Robins +26 more
TL;DR: This paper describes the establishment and current content of the ImmuneCODE™ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARS-CoV-2 virus, as well as over 135,000 high-confidence Sars-Cov-2-specific TCRs.
Journal ArticleDOI
CAR-T cell therapy: a potential new strategy against prostate cancer
Giuseppe Schepisi,Maria Concetta Cursano,Chiara Casadei,Cecilia Menna,Amelia Altavilla,Cristian Lolli,Claudio Cerchione,Giovanni Paganelli,Daniele Santini,Giuseppe Tonini,Giovanni Martinelli,Ugo De Giorgi +11 more
TL;DR: The principles that have guided the engineering of CAR-T cells and the specific prostatic antigens identified as possible targets for immunological and non-immunological therapies are reviewed and a state-of-the-art overview ofCAR-T cell therapy in PCa is provided.
Journal ArticleDOI
Immunotherapy in Acute Myeloid Leukemia: Where We Stand.
Alessandro Isidori,Claudio Cerchione,Naval Daver,Courtney D. DiNardo,Guillermo Garcia-Manero,Marina Konopleva,Elias Jabbour,Farhad Ravandi,Tapan M. Kadia,Adolfo de la Fuente Burguera,Alessandra Romano,Federica Loscocco,Giuseppe Visani,Giovanni Martinelli,Hagop M. Kantarjian,Antonio Curti +15 more
TL;DR: The role of the immune system in acute myeloid leukemia (AML) development, growth and recurrence has gained increasing interest in the past few years and a better understanding of immunological escape and systemic tolerance induced by AML blasts has been achieved.
Journal ArticleDOI
A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic Leukemia.
Massimo Martino,Caterina Alati,Filippo Antonio Canale,Gerardo Musuraca,Giovanni Martinelli,Claudio Cerchione +5 more
TL;DR: In this paper, the authors evaluated the effectiveness of CAR-T therapy in relapsed and refractory (R/R) B acute lymphoblastic leukemia (B-ALL) patients.